This inventor holds 1 USPTO granted patent. Top assignee: Massachusetts Institute of Technology. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Barbara Conradt: Innovator in Cell Death Research
Introduction
Barbara Conradt is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of cell biology, particularly in understanding the mechanisms of programmed cell death. Her work has implications for various biological processes and diseases.
Latest Patents
Barbara Conradt holds a patent for EGL-1, a new protein required for programmed cell death in C. elegans. This invention provides a novel protein, EGL-1, involved in cell death and methods for identifying compounds and genes that affect the cell death pathway. The patent highlights the importance of EGL-1 in the interaction with the BCL-2-like protein CED-9.
Career Highlights
Conradt is affiliated with the Massachusetts Institute of Technology, where she continues her research and innovation in cell biology. Her work has garnered attention for its potential applications in understanding and treating diseases related to cell death.
Collaborations
One of her notable collaborators is H Robert Horvitz, a distinguished scientist in the field. Their partnership has contributed to advancements in the understanding of programmed cell death.
Conclusion
Barbara Conradt's innovative work in cell death research exemplifies the impact of scientific inquiry on understanding complex biological processes. Her contributions continue to influence the field and inspire future research.